Literature DB >> 11139805

Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

M D Reller1.   

Abstract

This report reviews the current status of antithrombotic therapy, including anti-platelet therapy, in pediatric patients with congenital heart disease. The current medications utilized and dose recommendations are emphasized, and indications for their use are reviewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139805     DOI: 10.1007/s11886-001-0016-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  32 in total

Review 1.  Kawasaki syndrome.

Authors:  W H Mason; M Takahashi
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

2.  Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy.

Authors:  A Rothman; J Snyder
Journal:  Am Heart J       Date:  1991-02       Impact factor: 4.749

3.  Results of 546 Blalock-Taussig shunts performed in 478 patients.

Authors:  K A Al Jubair; M R Al Fagih; A S Al Jarallah; S Al Yousef; M A Ali Khan; A Ashmeg; Y Al Faraidi; W Sawyer
Journal:  Cardiol Young       Date:  1998-10       Impact factor: 1.093

4.  Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation.

Authors:  P Monagle; A Cochrane; B McCrindle; L Benson; W Williams; M Andrew
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

Review 5.  Thrombotic and bleeding complications of prosthetic heart valves.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1987-10       Impact factor: 4.330

6.  Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation.

Authors:  J P Donnelly; A Rosenthal; V P Castle; R D Holmes
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

7.  Arrhythmias and thromboembolic complications after the extracardiac Fontan operation.

Authors:  L K Shirai; D N Rosenthal; B A Reitz; R C Robbins; A M Dubin
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

Review 8.  Anticoagulation with warfarin in infants and children.

Authors:  M L Buck
Journal:  Ann Pharmacother       Date:  1996-11       Impact factor: 3.154

9.  Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children.

Authors:  R Hetzer; M Loebe; E V Potapov; Y Weng; B Stiller; E Hennig; V Alexi-Meskishvili; P E Lange
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

10.  Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor.

Authors:  P Massicotte; V Marzinotto; P Vegh; M Adams; M Andrew
Journal:  J Pediatr       Date:  1995-09       Impact factor: 4.406

View more
  2 in total

1.  The use of anticoagulation in pediatric cardiac disease.

Authors:  J R Boris; M A Harris
Journal:  Images Paediatr Cardiol       Date:  2003-07

2.  Neurosurgical Management and Outcomes of Cerebrovascular Disease in Pediatric Patients with Heart Disease.

Authors:  Daisuke Maruyama; Hiroharu Kataoka; Tetsu Satow; Hisae Mori; Yoshiro Ito; Eika Hamano; Shunichi Tanaka; Taichi Ishiguro; Hidekazu Chikuie; Jun C Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-07-12       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.